Tysabri Protects Against Relapse in Multiple Sclerosis, patients are a a high risk for developing PML. Many multiple sclerosis patients are also treated with natalizumab, which is an monoclonal antibody immunosuppressive medication. Putting the two together, some multiple sclerosis patients see a risk for extended use of Tysabri and desire a different treatment. “It’s difficult for patients to make decisions, In his experience, when the risk of PML for multiple scleros
Questions about multiple sclerosis (MS)? Here is a breakdown of the potential #MS symptoms as well as some ways to manage them: www.healthcentral.com/multiple-sclerosis/c/458275/167591/infographic?ap=2012 Pretty scary !